GT and Berkley Life Sciences present “Beyond The Bleeding Edge: Emerging Litigation Threats Facing the Medical Device Industry and Strategies and Tactics for Changing the Paradigm."
With the recent release of the Netflix Original, The Bleeding Edge, there has been a surge, both in the news and on social media, in criticism of the medical device industry and FDA’s premarket review process. This program is designed to assist clients in combating negative perceptions in the media, as well as the potential for courtroom bias, by highlighting how clients can manage the impact of media- and plaintiff-imposed narratives. Lori Cohen and Janna Nugent will discuss meaningful and strategic responses to the criticisms discussed in the documentary.